Skip to main content
. Author manuscript; available in PMC: 2015 May 22.
Published in final edited form as: Cell Rep. 2014 May 1;7(4):1310–1319. doi: 10.1016/j.celrep.2014.03.071

Figure 3.

Figure 3

(A) Frequency of the common cancer gene mutations in ovarian cancer patients who had no pSCNAbl (black) and those who have ≥4 pSCNAbl (grey). (B) Kaplan Meier curve showing difference in the survival patterns between the ovarian cancer patients who have no pSCNAbl (black) and those who have ≥4 pSCNAbl (red). The difference was statistically significant ( log rank test, p-value 3.64×10−4).